个性化文献订阅>期刊> Journal of Medicinal Chemistry
 

Design, Synthesis, and Biological Evaluation of Novel Constrained meta-Substituted Phenyl Propanoic Acids as Peroxisome Proliferator-Activated Receptor a and g Dual Agonists.

  作者 Suh, Young-Ger;Kim, Nam-Jung;Koo, Bon-Woong;Lee, Kwang-Ok;Moon, Sung-Hyun;Shin, Dong-Hyung;Jung, Jong-Wha;Paek, Seung-Mann;Chang, Dong-Jo;Li, Funan;Kang, Hyun-Jin;Le, Tuong Vy Thi;Chae, Yu Na;Shin, Chang Yell;Kim, Mi-Kyung;Lim, Joong In;Ryu, Jae-Sang;Park  
  选自 期刊  Journal of Medicinal Chemistry;  卷期  2008年51-20;  页码  6318-6333  
  关联知识点  
 

[摘要]In an effort to develop dual PPARa/g activators with improved therapeutic efficacy, a series of diaryl a-ethoxy propanoic acid compds. comprising two aryl groups linked by rigid oxime ether or isoxazoline ring were designed and synthesized and their biol. activities were examd. Most of the compds. possessing an oxime ether linker were more potent PPARg activators than the lead PPARa/g dual agonist, tesaglitazar in vitro. Compd. I, one of the derivs. with an oxime ether linker, was found to selectively transactivate PPARg (EC50 = 0.028 mM) over PPARa (EC50 = 7.22 mM) in vitro and lower blood glucose in db/db mice more than muraglitazar after oral treatment for 11 days.

 
      被申请数(0)  
 

[全文传递流程]

一般上传文献全文的时限在1个工作日内